BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7053066)

  • 1. Is there a connection between high affinity 3H-spiperone binding sites and DA-sensitive adenylate cyclase in corpus striatum?
    Marchais D; Bockaert J
    Biochem Pharmacol; 1980 May; 29(10):1331-6. PubMed ID: 7053066
    [No Abstract]   [Full Text] [Related]  

  • 2. [3H]Haloperidol and [3H]spiroperidol binding in rat striatum during ageing.
    Govoni S; Spano PF; Trabucchi M
    J Pharm Pharmacol; 1978 Jul; 30(7):448-9. PubMed ID: 27613
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
    [No Abstract]   [Full Text] [Related]  

  • 4. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional study of 3H-spiperone binding and the dopamine-sensitive adenylate cyclase in rat brain.
    Quik M; Iversen LL
    Eur J Pharmacol; 1979 Jul; 56(4):323-30. PubMed ID: 477728
    [No Abstract]   [Full Text] [Related]  

  • 6. A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone.
    Hartley EJ; Spuhler K; Prasad KN; Seeman P
    Brain Res; 1980 May; 190(2):574-7. PubMed ID: 6154511
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine metabolism, spiperone binding and adenylate cyclase activity in the adult rat hippocampus after ingrowth of dopaminergic neurones from embryonic implants.
    Bischoff S; Scatton B; Korf J
    Brain Res; 1979 Dec; 179(1):77-84. PubMed ID: 509234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsensitivity of the rat striatal dopaminergic system after treatment with bromocriptine: effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation.
    Quik M; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):141-5. PubMed ID: 212684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic ethanol treatment on adenylate cyclase activity in rat striatum.
    Lucchi L; Covelli V; Anthopoulou H; Spano PF; Trabucchi M
    Neurosci Lett; 1983 Sep; 40(2):187-92. PubMed ID: 6314211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apomorphine-induced rotation in the unilateral 6-OHDA-lesioned rat: relationship to changes in striatal adenylate cyclase activity and 3H-spiperone binding.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Neuropharmacology; 1979 Jul; 18(7):643-5. PubMed ID: 573871
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine receptors in the goldfish retina: 3H-spiroperidol and 3H-domperidone binding; and dopamine-stimulated adenylate cyclase activity.
    Redburn DA; Clement-Cormier Y; Lam DM
    Life Sci; 1980 Jul; 27(1):23-31. PubMed ID: 6105607
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased sensitivity of adenylate cyclase activity in the striatum of the rat to calmodulin and GppNHp after chronic treatment with haloperidol.
    Treisman GJ; Muirhead N; Gnegy ME
    Neuropharmacology; 1986 Jun; 25(6):587-95. PubMed ID: 3092124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
    Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic desipramine treatment influences D1 stimulation and D2 inhibition (dual control) of adenylate cyclase by dopamine in rat striatum.
    Okada F; Horikawa T; Tokumitsu Y; Nomura Y
    Neurochem Int; 1994 Jan; 24(1):23-7. PubMed ID: 8130732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting solubilized dopamine-sensitive adenylate cyclase.
    Marshall AM; Ramwani J; Mishra RK
    Biochem Pharmacol; 1983 Apr; 32(7):1237-41. PubMed ID: 6847713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3H-Spiroperidol binding and dopamine-stimulated adenylate cyclase: evidence for multiple classes of receptors in primate brain regions.
    Thal LJ; Makman MH; Ahn HS; Mishra RK; Horowitz SG; Dvorkin B; Katzman R
    Life Sci; 1978 Aug; 23(6):629-33. PubMed ID: 99609
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurohumoral regulation of adenylate cyclase activity in rat striatum.
    Walker JB; Walker JP
    Brain Res; 1973 May; 54():386-90. PubMed ID: 4145382
    [No Abstract]   [Full Text] [Related]  

  • 18. Increase in in vivo (3H) spiperone binding in the rat hippocampal formation and striatum after repeated treatment with haloperidol.
    Bischoff S
    Experientia; 1981; 37(9):1008-9. PubMed ID: 7297644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
    Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
    Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of the dopamine-sensitive adenylate cyclase in the striatum and hypothalamus of rat brain.
    Roufogalis BD; Thornton M; Wade DN
    J Pharm Pharmacol; 1979 Jan; 31(1):33-8. PubMed ID: 32363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.